Yulia Aspinall Q&A with ProQuest Dialog - the Pi2 Acquisition
Jinfo Article

28th August 2014 Sign in to MyJinfo or create an account be able to star items Subscribe via RSS to get updates as soon as Subscription Articles are added Tweet about this item on Twitter Share on Facebook Share on LinkedIn

By Yulia Aspinall

Abstract

Yulia Aspinall interviews ProQuest Dialog and Pi2 executives to find out more about the Pi2 acquisition and what the addition of this solution means for large and small pharmaceutical companies who need to access and manage product information or are involved in pharmacovigilance. The Q&A also looks at Pi2 systems such as the PinPoint Product Literature Database and the Drug Safety Triager.

Content Access

Access to Jinfo articles and reports is a benefit of a Jinfo Subscription.

Does your organisation have a Jinfo Subscription?
"Yes, we subscribe"

Please sign in here so that we can check your access to this item:

MyJinfo Login

Email:

Password:

  Forgotten password?

If this item has been shared with you by a colleague, please request a MyJinfo account.

"Not yet"

Gain access to this article with a Jinfo Subscription. It will help your organisation:

  1. Save time and money
  2. Re-invent information services
  3. Define, measure and communicate information value

Benefits and Pricing

Jinfo Testimonials
Testimonials


"Don't know"

Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.

Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.

Claire Laybats, Head of Commercial Development

Claire Laybats
Head of Commercial Development
claire.laybats@jinfo.com


About this article

Back to top ^


 « All Articles